diagnost
laboratori
play
central
role
recognit
new
emerg
infect
identif
sever
acut
respiratori
syndrom
sar
coronaviru
highlight
modern
diagnost
tool
collabor
clinician
public
health
profession
laboratorian
lead
rapid
character
new
respiratori
pathogen
similarli
develop
rapid
dissemin
polymeras
chain
reaction
pcr
method
detect
novel
influenza
strain
us
center
diseas
control
prevent
reli
recent
diagnost
technolog
play
import
role
respons
latest
influenza
pandem
event
remind
us
much
recent
develop
diagnost
improv
abil
identifi
respiratori
virus
nonvir
respiratori
pathogen
develop
laboratori
technolog
less
profound
gener
still
led
modest
improv
diagnost
capabl
diagnost
microbiolog
laboratori
routin
evalu
patient
suspect
respiratori
infect
continu
reli
method
use
long
time
microscopi
cultur
respiratori
tract
specimen
blood
cultur
detect
antigen
urin
upper
respiratori
specimen
serolog
recent
advanc
pneumonia
diagnost
mostli
occur
area
antigen
nucleic
acid
detect
despit
technolog
advanc
remain
sever
major
challeng
hinder
search
caus
respiratori
infect
particularli
pneumonia
challeng
includ
difficulti
collect
lower
respiratori
tract
specimen
problem
distinguish
colon
infect
poor
clinic
diagnost
sensit
assay
often
inadequ
evalu
new
diagnost
review
focus
recent
advanc
laboratori
diagnost
enabl
rapid
identif
respiratori
pathogen
assay
detect
microbi
antigen
bodi
fluid
use
diagnosi
respiratori
infect
mani
year
use
variou
format
immunofluoresc
enzymelink
immunosorb
assay
elisa
latex
agglutin
coagul
chromatograph
immunoassay
method
diagnost
tool
easili
appli
nearpati
test
develop
reliant
identif
suitabl
antigen
present
detect
quantiti
clinic
specimen
date
commerci
assay
develop
limit
rang
pathogen
wide
avail
assay
focus
detect
select
bacteri
pathogen
urin
detect
virus
respiratori
specimen
among
bacteri
respiratori
pathogen
assay
streptococcu
pneumonia
legionella
pneumophila
develop
newer
gener
immunochromatograph
test
detect
cpolysaccharid
cell
wall
antigen
urin
import
advanc
diagnosi
pneumococc
diseas
test
sensit
specif
greater
compar
convent
diagnost
method
detect
pneumococc
pneumonia
adult
unfortun
test
use
reliabl
children
also
detect
pneumococc
carriag
altern
pneumococc
antigen
diagnost
purpos
pneumolysin
shown
promis
result
although
none
demonstr
perform
better
exist
commerci
cpolysaccharid
antigen
assay
combin
pneumolysinspecif
antigen
detect
elisa
togeth
test
may
result
better
diagnost
yield
higher
specif
pneumolysin
detect
elisa
detect
solubl
legionella
antigen
urin
establish
valuabl
tool
diagnosi
legionnair
diseas
although
current
commerci
assay
reliabl
detect
infect
caus
legionella
pneumophila
serogroup
assay
intend
detect
legionella
although
perform
good
l
pneumophila
serogroup
detect
respiratori
viral
antigen
respiratori
secret
becom
import
diagnost
tool
antigen
detect
use
immunofluoresc
techniqu
pioneer
commerci
reagent
wide
use
detect
influenza
virus
respiratori
syncyti
viru
rsv
parainfluenza
virus
adenovirus
human
metapneumoviru
assay
requir
technic
expertis
advantag
allow
direct
evalu
specimen
qualiti
recent
commerci
rapid
diagnost
test
rdt
becom
wide
use
detect
influenza
rsv
directli
respiratori
specimen
diagnost
test
kit
produc
dipstick
cassett
card
contain
intern
control
posit
result
signal
color
chang
result
produc
test
within
minut
sensit
rapid
test
detect
season
influenza
clinic
specimen
rang
vari
viru
type
subtyp
time
specimen
collect
specimen
type
patient
age
test
compar
emerg
pandem
influenza
viru
rdt
wide
use
patient
triag
although
limit
data
avail
clinic
accuraci
sensit
assay
detect
new
strain
compar
realtim
pcr
specif
rdt
season
influenza
accord
avail
data
commerci
rsv
rdt
sensit
specif
compar
cultur
poorer
perform
observ
adult
may
relat
decreas
viral
titer
adult
compar
children
correctli
interpret
result
rdt
preval
influenza
rsv
diseas
commun
must
consid
peak
diseas
activ
posit
predict
valu
highest
falseneg
result
like
opposit
true
time
low
diseas
activ
diseas
preval
low
unknown
rdt
result
becom
difficult
interpret
limit
use
use
nucleic
acid
amplif
test
naat
transform
understand
respiratori
infect
demonstr
relev
new
agent
human
metapneumoviru
provid
new
insight
previous
recogn
one
rhinovirus
progress
commerci
clinic
applic
method
place
forefront
respiratori
diagnost
naat
possess
sever
advantag
tradit
techniqu
detect
respiratori
pathogen
test
improv
sensit
detect
organ
fastidi
longer
viabl
present
small
amount
naat
provid
rapid
genet
inform
regard
sequenc
evolut
geograph
variat
presenc
virul
factor
antibiot
resist
rapid
turnaround
time
allow
promin
role
patient
manag
abil
naat
test
multipl
pathogen
simultan
aid
diagnosi
nonspecif
respiratori
syndrom
outbreak
set
within
laboratori
naat
offer
enhanc
opportun
autom
lower
safeti
risk
cultur
detect
highli
virul
pathogen
among
naat
pcr
common
thoroughli
evalu
method
pcr
format
relev
respiratori
diagnost
classifi
convent
realtim
multiplex
platform
variou
amplicon
detect
method
gel
analysi
elisa
dna
hybrid
use
fluoresc
dye
chemic
tag
realtim
pcr
sever
featur
place
advantag
first
two
step
amplif
detect
combin
one
reaction
increas
speed
effici
test
reduc
risk
oper
error
crosscontamin
realtim
pcr
also
allow
possibl
quantifi
amount
start
nucleic
acid
materi
multiplex
pcr
system
multipl
pcr
target
sought
simultan
one
reaction
gain
wider
accept
particularli
among
commerci
assay
system
advantag
increas
number
rapid
diagnost
pathogen
test
without
increas
requir
amount
oper
time
specimen
materi
multiplex
assay
broaden
scope
respiratori
surveil
studi
also
led
increas
recognit
dual
tripl
infect
individu
note
tabl
assay
differenti
either
amplif
detect
step
amplif
step
multiplex
platform
must
balanc
compet
optim
pcr
condit
individu
target
must
overcom
problem
competit
inhibit
among
variou
primer
probe
platform
use
uniqu
method
address
issu
nest
primer
combin
complex
primer
structur
nontradit
nucleotid
assay
even
vari
detect
stage
common
task
differenti
detect
report
distinct
popul
amplifi
target
sever
platform
involv
solidphas
array
polystyren
microbead
suspens
use
fluoresc
dye
differenti
target
microchip
format
identifi
target
bind
specif
physic
locat
former
develop
platform
detect
target
wherea
latter
identifi
dozen
thousand
target
increas
breadth
target
afford
microarray
howev
come
expens
decreas
sensit
multiplex
pcr
product
also
distinguish
size
use
resolut
techniqu
agaros
gel
electrophoresi
differenti
weight
capillarybas
autosequenc
identifi
target
length
sequenc
mass
spectrometri
also
use
identif
either
attach
high
molecular
weight
tag
primer
analysi
specif
nucleotid
base
ratio
resolv
molecular
weight
regardless
platform
pcr
assay
requir
good
primer
design
take
consider
gene
target
gene
number
mobil
gene
speci
stabil
gene
presenc
mutat
bacteria
larg
genom
mani
gene
fulli
function
organ
includ
gene
replic
enzym
product
owe
larg
genom
size
mani
target
avail
specif
detect
bacteri
speci
housekeep
gene
gene
essenti
surviv
organ
desir
gene
target
conserv
region
hypervari
region
eg
rrna
gene
gene
found
multicopi
also
increas
sensit
pcr
assay
choic
viral
pathogen
gene
target
limit
limit
size
viral
genom
gene
highli
conserv
desir
target
pcr
allow
detect
mani
strain
gene
process
area
nucleotid
hypervari
caus
genet
mutat
avoid
chang
primer
probe
site
caus
poor
pcr
effici
potenti
falseneg
result
tabl
list
common
respiratori
pathogen
target
gene
publish
literatur
naat
difficult
interpret
studi
design
vari
rare
involv
headtohead
comparison
among
differ
assay
calcul
clinic
sensit
specif
complic
naat
often
sensit
refer
culturebas
standard
comparison
studi
result
also
problemat
use
differ
specimen
type
may
differenti
yield
pathogen
final
sever
naat
platform
requir
invest
special
equip
cost
recov
highvolum
test
therefor
naat
assay
respiratori
diagnosi
licens
clinic
use
daili
use
clinic
practic
remain
uncommon
promot
widespread
adopt
futur
develop
naat
diagnost
need
standard
evalu
method
particularli
comparison
refer
techniqu
reduc
complex
cost
better
demonstr
util
clinic
environ
although
naat
develop
import
respiratori
pathogen
clinic
applic
test
vari
perhap
area
naat
greatest
impact
diagnosi
infect
caus
respiratori
virus
respiratori
virus
detect
viral
nucleic
acid
sensit
diagnost
approach
current
gold
standard
name
cultur
direct
immunofluoresc
eventu
replac
naat
pcr
becom
diagnost
test
choic
respiratori
viral
infect
eg
influenza
current
influenza
pandem
use
epidemiolog
tool
character
role
virus
variou
diseas
state
naat
provid
result
rapidli
abl
detect
mani
viral
pathogen
unabl
readili
detect
cultur
perhap
respiratori
pathogen
consider
effort
direct
toward
develop
multiplex
assay
enabl
simultan
detect
multipl
viral
pathogen
given
increasingli
larg
number
respiratori
virus
challeng
task
need
improv
diagnost
tool
pneumococc
diseas
lead
evalu
sever
naat
pneumonia
pcr
sensit
detect
pneumonia
blood
sampl
rang
tendenc
higher
sensit
children
adult
find
posit
pneumococc
pcr
result
asymptomat
control
subject
complic
interpret
test
sputum
sampl
adult
pneumonia
pcr
posit
rang
although
unclear
often
reflect
upper
respiratori
tract
colon
rather
infect
refin
pcr
assay
includ
use
multipl
target
increas
specif
lyta
assay
potenti
offer
advantag
assay
quantif
pneumonia
dna
load
may
provid
addit
diagnost
prognost
inform
quantit
pcr
may
help
distinguish
colon
infect
higher
bacteri
burden
pneumococc
diseas
carrier
state
high
pneumococc
dna
load
blood
recent
shown
associ
sever
diseas
variou
set
naat
improv
abil
diagnost
laboratori
detect
respiratori
pathogen
difficult
cultur
mycoplasma
pneumonia
legionella
speci
chlamydophila
pneumonia
extens
evalu
antibodi
detect
assay
use
pcr
compar
standard
conclud
commerci
serolog
assay
detect
pneumonia
perform
suffici
sensit
specif
highlight
increas
import
naat
inde
pcr
consid
mani
method
choic
detect
pneumonia
infect
upper
lower
respiratori
tract
sampl
suitabl
test
pneumonia
pcr
although
throat
swab
nasopharyng
sampl
may
prefer
high
sensit
high
specif
conveni
practic
pcr
success
use
rapidli
diagnos
mycoplasma
pneumonia
outbreak
particularli
use
children
immunocompromis
patient
earlystag
diseas
legionnair
diseas
difficult
diagnos
naat
proven
use
adjunct
cultur
antigen
detect
pcr
repeatedli
shown
sensit
equal
greater
cultur
test
lower
respiratori
specimen
legionella
dna
also
detect
nonrespiratori
specimen
urin
serum
peripher
leukocyt
although
test
specimen
type
well
establish
abbrevi
dfa
direct
fluoresc
assay
nd
determin
tcid
tissu
cultur
infect
dose
need
produc
chang
pcr
extens
evalu
rapid
diagnosi
c
pneumonia
infect
use
variou
assay
standard
approach
c
pneumonia
diagnost
test
publish
us
center
diseas
control
prevent
canadian
laboratori
center
diseas
control
howev
still
evalu
extens
use
clinic
sampl
great
varieti
method
use
make
difficult
make
firm
conclus
perform
complic
matter
signific
interlaboratori
discord
detect
rate
record
assay
diagnost
yield
pcr
consist
greater
cultur
test
nasopharyng
sampl
bordetella
pertussi
pcr
remain
posit
longer
period
onset
symptom
thu
use
individu
present
late
ill
investig
pertussi
outbreak
combin
pcr
cultur
sampl
obtain
week
less
ill
onset
pcr
alon
sampl
obtain
week
ill
onset
prove
diagnost
use
pcr
greater
sensit
cytolog
method
detect
pneumocysti
jiroveci
although
difficult
interpret
common
find
pcrposit
sampl
neg
standard
method
latter
may
reflect
p
jiroveci
colon
uncertain
clinic
signific
perform
pcr
shown
vari
differ
assay
although
result
correl
well
clinic
evid
pneumocysti
pneumonia
need
improv
diagnost
method
tuberculosi
focus
attent
potenti
role
naat
advanc
area
rel
slow
naat
mycobacteria
fail
provid
greater
sensit
culturebas
method
rel
high
falseneg
rate
naat
mycobacterium
tuberculosi
probabl
reflect
combin
paucibacillari
natur
sampl
presenc
inhibitor
sampl
suboptim
dna
extract
method
situat
chang
new
develop
rapid
diagnosi
antibiot
suscept
test
direct
detect
tuberculosi
respiratori
sampl
commerci
assay
high
specif
variabl
sensit
smearposit
sampl
smearneg
sampl
consequ
recommend
use
test
restrict
smearposit
sampl
evalu
pcr
diagnosi
tuberculosi
highpreval
popul
promis
altern
strategi
develop
diagnos
tuberculosi
molecular
tool
includ
detect
mycobacteri
dna
urin
direct
detect
respiratori
specimen
microarray
naat
discuss
herein
target
known
pathogen
naat
fail
identifi
agent
addit
tool
need
pursu
etiolog
diagnosi
might
indic
outbreak
set
addit
method
includ
microarray
highthroughput
sequenc
proteom
also
potenti
develop
tool
pathogen
discoveri
breath
analysi
excit
new
area
enorm
diagnost
potenti
alveolar
breath
contain
mani
biomark
deriv
blood
passiv
diffus
across
alveolar
membran
also
contain
direct
marker
lung
injuri
breath
test
noninvas
easili
repeat
requir
minim
specimen
workup
variou
test
methodolog
sampl
type
use
breath
research
usual
involv
measur
exhal
perman
gase
detect
volatil
organ
compound
analysi
exhal
breath
condens
use
breath
analysi
investig
respiratori
infect
yet
extens
evalu
electron
nose
devic
detect
volatil
molecul
interact
chemic
sensor
assay
base
reactiv
multipl
sensor
volatil
molecul
electron
signatur
gener
test
exhal
breath
portabl
electron
nose
use
diagnos
pneumonia
mechan
ventil
patient
clinic
impact
devic
need
evalu
could
use
trigger
diagnost
studi
pneumonia
bronchoscopi
microorgan
produc
volatil
metabolit
may
use
biomark
detect
biomark
breath
sampl
ga
chromatographymass
spectroscopi
similar
method
may
provid
etiolog
diagnosi
respiratori
tract
infect
ideal
specif
biomark
need
identifi
may
difficult
discov
uniqu
marker
pathogen
produc
suffici
quantiti
enabl
detect
potenti
biomark
report
respiratori
pathogen
aspergillu
fumigatu
tuberculosi
still
uncertain
whether
prove
use
clinic
diagnost
tool
diagnost
test
respiratori
infect
continu
evolv
becom
userfriendli
antigendetect
assay
immunochromatograph
similar
format
rapid
simpl
perform
easili
develop
nearpati
test
method
among
attract
diagnost
tool
develop
reliant
discoveri
suitabl
antigen
reliabl
detect
readili
obtain
specimen
naat
develop
stage
multiplex
assay
detect
common
respiratori
pathogen
commerci
avail
although
rigor
evalu
clinic
set
improv
design
perform
expect
emphasi
place
clarifi
clinic
use
naat
develop
standard
method
produc
even
userfriendli
platform
explor
role
quantit
assay
new
approach
respiratori
pathogen
detect
desper
need
breath
analysi
excit
new
area
enorm
potenti
interest
follow
progress
area
next
year
